Arvee Laboratories (India) Ltd

As of 05-Dec, Arvee Laboratories (India) Ltd witnessed a significant price increase of 19.96%, closing at ₹197.48. This sharp rise comes despite the company’s recent weak fundamental performance, highlighting a complex interplay between market sentiment and financial realities.

Arvee Laborat has experienced significant fluctuations in financial performance, with net sales and profits declining from March 2023 to March 2025, despite slight improvements in cash flow. Key metrics such as operating profit and earnings per share also decreased during this period.

Arvee Laborat's historical performance shows significant fluctuations, with net sales and profits declining from March 2023 to March 2025, while cash flow from operating activities improved. Key metrics include a drop in profit after tax from 4.12 Cr to 2.15 Cr and earnings per share decreasing from 3.74 to 1.95.

Arvee Laborat has experienced significant fluctuations in financial performance, with net sales and profits declining from March 2023 to March 2025, despite a slight improvement in cash flow from operating activities. Overall, the company faced challenges with decreasing revenues and profitability during this period.

Arvee Laborat's historical performance shows a decline in net sales and total operating income from 62.48 Cr in March 2023 to 38.49 Cr in March 2025, while operating profit decreased from 8.41 Cr to 3.62 Cr during the same period. However, profit after tax rose to 2.15 Cr in March 2025, despite being lower than the 4.12 Cr in March 2023.

Arvee Laborat's historical performance shows significant fluctuations, with net sales peaking at 62.48 Cr in March 2023 before declining to 38.49 Cr by March 2025, alongside decreases in operating profit and net profits during the same period. Total liabilities and assets also decreased, while cash flow from operating activities improved slightly.

Arvee Laborat. has shown fluctuating financial performance, with net sales increasing to 38.49 Cr in Mar'25 from 30.35 Cr in Mar'24, but down from 62.48 Cr in Mar'23. Profitability metrics improved recently, with profit after tax rising to 2.15 Cr in Mar'25, despite a decline in total assets.

As of 06-Oct, Arvee Laboratories (India) Ltd is priced at 164.01, showing a short-term gain but a concerning long-term outlook with a negative return of 7.86% over the past year and poor financial performance. The stock is underperforming compared to the broader market, with declining investor interest and significant drops in net sales and profits.

As of 30-Sep, Arvee Laboratories (India) Ltd's stock price has declined to 154.85, down 5.0%, underperforming its sector and showing significant drops in delivery volume and profitability. Despite past strong returns, recent negative trends and high valuation concerns suggest a challenging outlook for the company.

As of 26-Sep, Arvee Laboratories (India) Ltd's stock price is declining at 165.34, down 4.15%, with significant drops in delivery volume and underperformance compared to its sector. Despite a strong long-term performance, recent negative financial results and high valuation relative to peers are contributing to its downward trend.

Arvee Laboratories (India) Ltd, a microcap in the Chemicals & Petrochemicals sector, faced notable trading activity as its stock hit the lower circuit limit. The total traded volume was around 0.0084 lakh shares, with a significant drop in delivery volume, indicating reduced investor interest and liquidity challenges.